Key result
Periodontal disease links to cardiovascular comorbidities, with periodontal therapy offering potential risk-reduction value.
Why the study?
The potential causal relationship between periodontitis and cardiovascular disease comorbidities and the impact of periodontal therapy on cardiovascular risk require updated evidence synthesis.
Does periodontal therapy improve management of cardiovascular comorbidities and reduce cardiovascular disease risk?
Does periodontal therapy improve management of cardiovascular comorbidities and reduce cardiovascular disease risk?
This review summarizes the evidence linking periodontal disease to cardiovascular comorbidities and discusses the potential value of periodontal therapy in reducing overall cardiovascular risk.
Several studies have examined a potential relationship between periodontal disease and cardiovascular disease. This article aims to update the evidence for a potential association by summarizing the evidence for causality between periodontitis and comorbidities linked to cardiovascular disease, including hypertension, atrial fibrillation, coronary artery disease, diabetes mellitus, and hyperlipidemia. We additionally discuss the evidence for periodontal therapy as a means to improved management of these comorbidities, with the larger goal of examining the value of periodontal therapy on reduction of cardiovascular disease risk.
No takes yet. Share an insight, caveat, or question.
Gajagowni et al. (2023) conducted a review in Cardiovascular disease and periodontitis. Periodontal disease and periodontal therapy was evaluated. This review summarizes the evidence linking periodontal disease with cardiovascular comorbidities and explores the potential value of periodontal therapy in reducing cardiovascular disease risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: